2024-01-20 14:03:49
American scientists are reportedly working on a “space vaccine,” which could also improve the lives of aging populations.
Researchers at the University of Central Florida (UCF) would collaborate with biotechnology company Vaxxinity to develop a vaccine to prevent and alleviate muscle and bone weakening, the Miami Herald Saturday morning.
This collaboration, supported by state funding, aims to treat atrophy as well as bone and muscle loss, a common health problem among astronauts who make long-term weightless journeys, but also among the elderly .
The number of people aged 85 and older is expected to triple by 2060 in the United States. Research that can lead to longer, healthier lives is becoming increasingly important to American researchers in this context.
“We look forward to collaborating with Vaxxinity on this research and applying their unique technology to benefit our planet’s aging population and future space travelers,” said Vaxxinity’s vice president of business affairs in an announcement. health and dean of the UCF School of Medicine, Deborah German.
If all goes well, human clinical trials for vaccines could begin as early as 2025, Lou Reese, co-founder and executive chairman of Vaxxinity, said at Miami Herald.
1705816677
#Developed #astronauts #vaccine #seniors